| Deutsch English Français Italiano |
|
<20MKp3bUTt4YFg3t_2Crmhb91yc@jntp> View for Bookmarking (what is this?) Look up another Usenet article |
Path: ...!3.eu.feeder.erje.net!feeder.erje.net!proxad.net!feeder1-2.proxad.net!usenet-fr.net!pasdenom.info!from-devjntp Message-ID: <20MKp3bUTt4YFg3t_2Crmhb91yc@jntp> JNTP-Route: nemoweb.net JNTP-DataType: Article Subject: Re: L'homologation d'un vaccin =?UTF-8?Q?combin=C3=A9=20grippe-covid=20su?= =?UTF-8?Q?spendue?= References: <CY3QO.978916$XGr1.929339@fx10.ams4> <JMdRO.1001537$XGr1.26882@fx10.ams4> <vfak88$20itv$1@dont-email.me> <16oSO.1015372$Z7Y1.799761@fx14.ams4> <fM6C-kBhjGsjmpmkARFd8tALdHw@jntp> <vg09kq$1lqiu$1@solani.org> <YR-0Wt-vUXcbgkm8SJVvntT3-50@jntp> <vg0c38$9hpk$1@solani.org> <KO_RVkjfL1ZJ_khs9XtsplI6-GY@jntp> <RgZUO.3246419$grz1.94797@fx03.ams4> Newsgroups: fr.misc.engueulades JNTP-HashClient: 8SIFGQ_hysKIueSwRh5IvwmBMfs JNTP-ThreadID: CY3QO.978916$XGr1.929339@fx10.ams4 JNTP-Uri: https://nemoweb.net/?DataID=20MKp3bUTt4YFg3t_2Crmhb91yc@jntp User-Agent: Nemo/1.0 JNTP-OriginServer: nemoweb.net Date: Fri, 01 Nov 24 08:12:47 +0000 Organization: Nemoweb JNTP-Browser: Mozilla/5.0 (Windows NT 10.0; Win64; x64; rv:132.0) Gecko/20100101 Firefox/132.0 Injection-Info: nemoweb.net; posting-host="48db87d9176ce6969124ceb9d6b05e62333c6c22"; logging-data="2024-11-01T08:12:47Z/9082918"; posting-account="2@nemoweb.net"; mail-complaints-to="julien.arlandis@gmail.com" JNTP-ProtocolVersion: 0.21.1 JNTP-Server: PhpNemoServer/0.94.5 MIME-Version: 1.0 Content-Type: text/plain; charset=UTF-8; format=flowed Content-Transfer-Encoding: 8bit X-JNTP-JsonNewsGateway: 0.96 From: Duzz' <jsuis@jreste.invalid> Bytes: 2001 Lines: 10 Le 01/11/2024 à 06:01, Paul Aubrin a écrit : > Le 31/10/2024 à 17:51, Duzz' a écrit : >> >>> https://www.vidal.fr/medicaments/substances/ivermectine-4063.html >> >> Merci pour cette explication à l'origine de tes âneries. [2] > > Cet article du Vidal n'est en aucun cas une source d'âneries. Merci d'avoir confirmé votre ânerie et l'arnaque de sa prescription contre le SARS-CoV-2.